- $2.34bn
- $2.34bn
- $12.80m
Germany's Ottobock to wait until September to list amid choppy markets - sources
Brief: Ekso Bionics Holdings Inc Says Steven Sherman To Be Appointed CEO
Brief: Ekso Bionics Reports Preliminary Q4 And Full Year 2021 Financial Results
Brief: Ekso Bionics Appoints Corinna Lathan To Board Of Directors
Brief: Ekso Bionics Announces Eksonr Multi-Unit Order By Nebraska Fraternal Order Of Eagles
Brief: Ekso Bionics Posts Q3 Loss Per Share Of $0.17
Ekso Bionics Holdings Inc expected to post a loss of 25 cents a share - Earnings Preview
Ekso Bionics Holdings Inc expected to post a loss of 25 cents a share - Earnings Preview
Ekso Bionics Holdings Inc reports results for the quarter ended in June - Earnings Summary
Brief: Ekso Bionics Reports Second Quarter 2021 Results
Ekso Bionics Holdings Inc expected to post a loss of 25 cents a share - Earnings Preview
German artificial limb maker Ottobock plans blockbuster 2022 IPO -sources
Ekso Bionics jumps as its robotic exoskeleton to be available at some hospitals
Brief: Ekso Announces Expanded Partnership With Kindred Healthcare
Ekso Bionics Holdings Inc reports results for the quarter ended in March - Earnings Summary
Ekso Bionics Holdings Inc expected to post a loss of 24 cents a share - Earnings Preview
Brief: Ekso Bionics Reports Q4 And Year End 2020 Results
Brief: Ekso Bionics Says Increases Previously Announced Bought Deal Offering Of Common Stock To $40 Million
Brief: Ekso Bionics Announces $10 Million Bought Deal Offering Of Common Stock